UniCredit Call 10.5 IBE1 18.12.20.../ DE000HD313Q2 /
21.06.2024 19:40:32 | Изменение+0.050 | Бид21:59:12 | Предложение21:59:12 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
1.750EUR | +2.94% | - Величина цены спроса: - |
- Величина цены предложения: - |
IBERDROLA INH. EO... | 10.50 - | 18.12.2024 | Call |
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
6:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
3:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
3:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница